Androgen receptor responsive enhancers are flanked by consistently-positioned H3-acetylated nucleosomes.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. An androgen response element driven reporter assay for the detection of androgen receptor activity in prostate cells.PloS one · 2017
   Article
2. Histone H2A.Z deregulation in prostate cancer. Cause or effect?Cancer metastasis reviews · 2014
   Review
3. Chromatin accessibility reveals insights into androgen receptor activation and transcriptional specificity.Genome biology · 2012
   Article
4. Androgen receptor serine 81 mediates Pin1 interaction and activity.Cell cycle (Georgetown, Tex.) · 2012
   Article
5. Dynamic nucleosome-depleted regions at androgen receptor enhancers in the absence of ligand in prostate cancer cells.Molecular and cellular biology · 2011
   Article
6. Control of nuclear receptor function by local chromatin structure.The FEBS journal · 2011
   Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

4 authors.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as